Prognostic Impact of Angiogenesis in Nonmuscle Invasive Bladder Cancer as Defined by Microvessel Density after Immunohistochemical Staining for CD34

REFERENCES

• Saint F, Salomon L, Quintela R. Do prognostic parameters of remission versus relapse after bacillus Calmette-Guerin (BCG) immunotherapy exist? Analysis of a quarter century of literature. Eur Urol. 2003;43:351–361.
   PubMed Web of Science ®Google Scholar
• Kohler HH, Barth PJ, Siebel A, et al. Quantitative assessment of vascular surface density in renal cell carcinomas. Br J Urol. 1996;77:650–654.
   PubMedGoogle Scholar
• Yorü koğlu K, Sağol Ö, Özkara E, et al. Comparison of microvascularization in diagnostic needle biopsies and radical prostatectomies in prostate carcinoma. Eur Urol. 1999;35:109–112.
   PubMed Web of Science ®Google Scholar
• Stein JP, Grossfeld GD, Ginsberg D, et al. Prognostic markers in bladder cancer: a contemporary review of the literature. J Urol. 1998;160:645–659.
   PubMed Web of Science ®Google Scholar
• Bochner BH, Cote RJ, Weidner N, et al. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst. 1995;87: 1603–1612.
   PubMed Web of Science ®Google Scholar
• Philip EA, Stephenson TJ, Reed MWR. Prognostic significance of angiogenesis in transitional cell carcinoma of the human urinary bladder. Br J Urol.1996;77:352–357.
   PubMedGoogle Scholar
• Fina L, Molgaard H, Robertson D, et al. Expression of the CD34 gene in vascular endothelial cells. Blood. 1990;75:2417–2420.
   PubMed Web of Science ®Google Scholar
• Traweek ST, Kandalaft PL, Mehta P, Battifora H. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am J Clin Pathol. 1991;96:25–31.
   PubMed Web of Science ®Google Scholar
• Kuzu I, Bicknell R, Harris AL, Jones M, Gatter KC, Mason DY. Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumors. J Clin Pathol. 1992;45:143–148.
   PubMed Web of Science ®Google Scholar
• Schaerer L, Schmid MH, Mueller B, Dummer RG, Burg G, Kempf W. Angiogenesis in cutaneous lymphoproliferative disorders: microvessel density discriminates between cutaneous B-cell lymphomas and B-cell pseudolymphomas. Am J Dermatopathol. 2000;22:140–14.
   PubMed Web of Science ®Google Scholar
• Bartoletti R, Cai T, Nesi G, Sardi I, Rizzo M. Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: relationship with clinical course at 10 years follow-up. Oncol Rep. 2005;14:251–255.
   PubMed Web of Science ®Google Scholar
• Korkolopoulou P, Konstantinidou AE, Kavantzas N, et al. Morphometric microvascular characteristics predict prognosis in superficial and invasive bladder cancer. Virchows Arch. 2001;438:603–611.
   PubMed Web of Science ®Google Scholar
• Sauter G, Algaba F, Amin MB, et al. Non invasive urothelial tumors. In: Elbe JN, Sauter G, Epstein JI, Sesterhenn IA, eds. Pathology and Genetics: Tumors of the Urinary System and Male Genital Organs. Lyon: IARC Press;2004:110–111.
   Google Scholar
• Martinez-Pineiro JA, Flores N, Isorna S, et al., for CUETO (Club Urologico Espanol de Tratamiento Oncologico). Long-term follow-up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacilli Calmette-Guerin with a reduced dose of 27 mg in superficial bladder cancer. BJU Int. 2002;89:671–680.
   PubMed Web of Science ®Google Scholar
• Dickinson AJ, Fox SB, Persad, RA, Hollyer J, Sibley GN, Harris AL. Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Br J Urol. 1994;74:762–766.
   PubMedGoogle Scholar
• Jaeger TM, Weidner N, Chew K, et al. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J Urol. 1995;154:69–71.
   PubMed Web of Science ®Google Scholar
• Sagol O, Yorukoglu K, Sis B, et al. Does angiogenesis predict recurrence in superficial transitional cell carcinoma of the bladder? Urology. 2001;57:895–899.
   PubMed Web of Science ®Google Scholar
• Dinney CP, Babkowski RC, Antelo M, et al. Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder. J Urol. 1998;160:1285–1290.
   PubMed Web of Science ®Google Scholar
• Ozer E, Mungan MU, Tuna B, Kazimoglu H, Yorukoglu K, Kirkali Z. Prognostic significance of angiogenesis and immunoreactivity of cathepsin D and type IV collagen in high-grade stage T1 primary bladder cancer. Urology. 1999;54:50–55.
   PubMed Web of Science ®Google Scholar
• Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1–8.
   PubMed Web of Science ®Google Scholar
• Jaeger TM, Weidner N, Chew K, et al. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J Urol. 1995;154:69–71.
   PubMed Web of Science ®Google Scholar
• Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol. 1995;147:9–19.
   PubMed Web of Science ®Google Scholar
• Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol. 1993;143:401–409.
   PubMed Web of Science ®Google Scholar
• Gasparini G, Weidner N, Maluta S, et al. Intratumoral microvessel density and p53 protein: correlation with metastases in head-and-neck squamous cell carcinoma. Int J Cancer. 1993;55:739–744.
   PubMed Web of Science ®Google Scholar
• Tenderenda M, Rutkowski P, Jesoniek-Kupnicka D, Kubiak R. Expression of CD34 in gastric cancer and its correlation with histology, stage, proliferation activity, p53 expression and apoptotic index. Pathol Oncol Res. 2001;7:129–134.
   PubMedGoogle Scholar
• Yoshiji H, Gomez DE, Shibuya M, Thorgeirsson UP. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res. 1996;56:2013–2016.
   PubMed Web of Science ®Google Scholar
• Holmgren L, O’Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med. 1995;1:149–153.
   PubMed Web of Science ®Google Scholar
• Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene. 1991;6:1677–1683.
   PubMed Web of Science ®Google Scholar
• de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science. 1992;255:989–991.
   PubMed Web of Science ®Google Scholar